Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Perrigo Company plc

PRGO•NYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$14.56
$-0.41(-2.74%)
U.S. Market opens in 17h 26m

Perrigo Company plc (PRGO) Stock Overview

Explore Perrigo Company plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2B
P/E Ratio-40.05
EPS (TTM)$-0.21
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$18.37
3 Months$11.42
1 Year Target$10.13

PRGO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Perrigo Company plc (PRGO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.97, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $10.13.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -40.05 and a market capitalization of 2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.50%
5-Day Change
2.92%
1-Month Change
-0.83%
3-Month Change
22.06%
6-Month Change
-36.75%
Year-to-Date (YTD) Change
7.74%
1-Year Change
-40.71%
3-Year Change
-59.12%
5-Year Change
-64.47%
All-Time (Max) Change
28.68%

Contact Information

https://www.perrigo.com
353 1 709 4000
The Sharp Building, Dublin, NaN, 2

Company Facts

83,790 Employees
IPO DateDec 17, 1991
CountryIE
Actively Trading

Frequently Asked Questions